Cell Culture and Upstream Processing conference

IBC is organizing a conference on Cell Culture and Upstream Processing from 8-10 December at Hilton San Diego Resort, San Diego, CA. The event offers a comprehensive view of the latest developments in laboratory and production scale cell culture processes from leading international experts in industry and academia. It features case studies and sessions from leading international experts and provides the opportunity to learn more in the critical area of nutrient system sourcing and selection and also how to improve the yield and efficiency of the cell culture production processes. In addition, there is a pre-conference workshop on Cell Culture Media Development and Optimization.

For further information, contact: reg@ibcusa.com

Safety Biomarkers

EuroForum is organizing a conference on "Safety Biomarkers" from 26-27 January 2004 at Eden Hotel, Wolff Munich, Germany. This is Europe's first international conference dedicated solely to discussion of safety biomarkers and the key challenges in the development and application of improved biomarkers of toxicity. This event will bring together an impressive group of experts working in this field from all over the world. The conference will focus on approval process for biomarker acceptance, application of current biomarkers in clinical and preclinical studies, methods for the identification of novel non-invasive clinical biomarkers, development of bridging biomarkers, etc.

For further details, contact: niamh@ef-international.co.uk

BIO-Asia Clinical Stage Partnering conference

The Biotechnology Industry Organization (BIO) is organizing the first-ever BIO-Asia Clinical Stage Partnering Conference on 2-3 February, 2004, in Tokyo, Japan, at the Grand Hyatt Tokyo. This event is a select, customized partnering forum that will introduce U.S. and European clinical-stage drug development companies to Japanese and other Asian pharmaceutical companies. The conference features private, one-on-one meetings pre-arranged between senior-level executives.

For further information, contact: bioasia@bio.org

Gene Therapy for Cancer

The International Society of Cancer Gene Therapy, in association with the Sidney Kimmel Cancer Center, a Sharp HealthCare affiliate, is organizing an international conference on Gene Therapy of Cancer on 11-13 December, at Hotel delCoronado, San Diego, California.

Leading researchers from around the world will present the latest results of their pre-clinical and clinical studies of cancer treatment using gene therapy technology. The design of the program includes sessions focusing on vector systems, tumor suppressors, apoptosis, antisense-ribozymes-RNAsi, hematopoietic gene transfer, drug resistance, therapy sensitization, immunotherapy and vaccines. Each topic session will begin with an overview of the field and the current status of human clinical trials.

For further details, contact: christin@pcmisandiego.com

Process Validation for Biologicals

IBC is organizing a conference on "Process Validation for Biologicals" from 23-24 Feburary, 2004 at Sheraton San Diego Hotel and Marina-San Diego, CA. The conference focuses on developing and implementing successful validation strategies and procedures for manufacturing biologicals while adhering to GMP and other regulatory guidances in a cost-effective manner. The event is being held concurrently with IBC's inaugural conference on 21 CFR Part 11: Ensuring Compliance and Mitigating Risk.

For further information, contact: reg@ibcusa.com

BioAsia 2004

BioAsia 2004 being held in Hyderabad on 26-28 Feburary, 2004 is promoted by the Government of Andhra Pradesh and Genome Valley, Hyderabad. This global bio business forum will help in building global alliances and collaborations, showcasing products/services and networking with industry leaders, research scientists and media analysts.

The event consists of a tradeshow, conference, B2B forum and a knowledge pavilion. The conference will cover advances in genomics, proteomics, structural genomics and structural design that are likely to impact pharmaceutical design, medicine, agriculture, forestry, marine life, animal husbandry and various other subjects.

For further information, visit: www.bioasia2004.org